✦ LIBER ✦

Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma

✍ Scribed by Ravi D. Rao; Shernan G. Holtan; James N. Ingle; Gary A. Croghan; Lisa A. Kottschade; Edward T. Creagan; Judith S. Kaur; Henry C. Pitot; Svetomir N. Markovic

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21611

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel plus carb

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi

Triplet combination of gemcitabine, pacl

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

✍ Swan Swan Leong; Joseph Wee; Sandeep Rajan; Chee Keong Toh; Wan Teck Lim; Siew W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

Comparison of outcomes for elderly patie

Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer

✍ Suresh Ramalingam; Michael C. Perry; Renato V. La Rocca; David Rinaldi; Preston 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

A phase 2 study of tasisulam sodium (LY5

A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma

✍ John M. Kirkwood; Rene Gonzalez; Douglas Reintgen; Philip R. Clingan; Robert R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Outpatient combination chemoimmunotherap

Outpatient combination chemoimmunotherapy for patients with metastatic melanoma : Results of a Phase I/II trial

✍ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl

Phase II study of paclitaxel and epirubi

Phase II study of paclitaxel and epirubicin as first-line treatment in patients with metastatic nonsmall cell lung carcinoma

✍ Giovanni L. Ceresoli; Stefania Dell'Oro; Paolo Passoni; Eugenio Villa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views